CIBC Bancorp USA’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$94.8M Sell
424,861
-110,850
-21% -$25.8M 0.12% 164
2026
Q2
$127M Sell
535,711
-349,644
-39% -$72.7M 0.15% 145
2026
Q1
$187M Buy
+885,355
New +$191M 0.25% 103
2025
Q3
$6.06M Buy
+38,620
New +$5.97M 0.03% 365

Other funds holding CAH

CIBC Bancorp USA's CAH Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Cardinal Health (CAH) stake by 21% in Q3 2026, selling an estimated $25.8M and leaving 424,861 shares worth $94.8M. The position accounts for 0.12% of the portfolio, ranked #164.

CIBC Bancorp USA first reported a position in CAH in Q3 2025 and has held it in 4 quarters since. The position peaked at $187M in Q1 2026. 1,272 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • CIBC Bancorp USA held 424,861 shares of Cardinal Health worth $94.8M as of Q3 2026.
  • CIBC Bancorp USA sold 110,850 Cardinal Health shares in Q3 2026, an estimated $25.8M.
  • Cardinal Health made up 0.12% of CIBC Bancorp USA's portfolio in Q3 2026, its #164 holding.
  • CIBC Bancorp USA first reported a position in Cardinal Health in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Cardinal Health position peaked at $187M in Q1 2026.
  • 1,272 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.